Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medexus Pharmaceuticals Inc MEDXF


Primary Symbol: T.MDP

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA... see more

TSX:MDP - Post Discussion

Medexus Pharmaceuticals Inc > If interested in short postion for MDP
View:
Post by GoldenArm on Apr 30, 2021 11:49am

If interested in short postion for MDP

Still here and like you all still waiting to hear from these mimes as to what is up with te Nasdaq listing. Short position dropped from a month ago.

Shares Short (Apr. 15, 2021) 36.02k
Short Ratio (Apr. 15, 2021) 0.58
Short % of Float (Apr. 15, 2021) N/A
Short % of Shares Outstanding (Apr. 15, 2021) 0.19%
Shares Short (prior month Mar. 15, 2021)  56.01k
Comment by Finallytherock on Apr 30, 2021 12:18pm
Nasdaq uplisting takes time and there can be delays which may be out of the company's hands. The stock is ridiculously undervalued. FDA approval of treosulphan will be enormous for them
Comment by oceaneleven on May 05, 2021 11:22am
nasdaq listing doesn't take that long..usually 4-6 weeks..it's been 3 months...company siad they would keep us updated on this but haven't shared anything so this makes me think they got approval already but not quite ready to share(lol not the case)...Where is the update??? I am going to have to do some deep searching the web to find out what is going on with it...
Comment by Finallytherock on May 05, 2021 12:28pm
the nasdaq approval often takes longer than you think and hope. if they were approved to list, i don't know why they wouldn't disclose it
Comment by Rockafellow on May 05, 2021 1:08pm
While urul researching this out u better get over to IVS & find out what desjardine is up to & why no trading ... Ur pal is spraying again over there. ... ... Over there, over there,... I will c u over there  ..
Comment by Finallytherock on May 05, 2021 3:55pm
another informative post, thank you
Comment by GoldenArm on May 07, 2021 11:10am
With Covid I have a feeling that the 6 weeks is now 12 weeks or more. Week 1. Company submits application for listing and Nasdaq Listing Qualifications Staff begins its review. Weeks 2-3. Staff completes its preliminary review and prepares comment letter. Weeks 3-4. Company addresses any issues raised by Staff. Weeks 5-6. Staff completes their review and company is approved for listing.
Comment by Rockafellow on May 07, 2021 7:35am
US citizens can trade Medexus under the symbol OTC:MEDXF trading today @ $6.01 CDN ... . ... ...  No NASDAQ symbol yet. ... .. ... . . Q1 fins should b out shortly in May .... Estimate revenue is $27.43 mil for latest quarter. ... That's all folks!!!!!!!!
Comment by Rockafellow on May 18, 2021 12:14pm
Why pay big bucks in $US when u can buy on the OTC??? ... ... ... . Doesn't make since 2 me. ... Waste of money!!!! . ... . Thinking 4Q profit should b around $28 mil US or more & if treosulfan approval this is an easy $10 CDN sp ehh Ocean. ... ... ... ... Giddie up go.. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities